Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

Pfizer's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Victorian babies will be safer from Respiratory Syncytial Virus (RSV) this winter, with a long-acting immunisation available ...

The long-acting Respiratory Syncytial Virus (RSV) immunisation is now available free for eligible families until September 30 ...